Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose

The objective of this study was to examine the effect of renal sodium–glucose cotransporter inhibition with empagliflozin on the fasting plasma glucose (FPG) concentration and β-cell function in subjects with impaired fasting glucose (IFG). Eight subjects with normal fasting glucose (NFG) and eight...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes
Main Authors: Abdul-Ghani, Muhammad, Al Jobori, Hussein, Daniele, Giuseppe, Adams, John, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A.
Format: Artigo
Language:Inglês
Published: American Diabetes Association 2017
Subjects:
Complications
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301341/
https://ncbi.nlm.nih.gov/pubmed/28611037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-0055
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items